Endurant Capital Management’s AtriCure ATRC Stock Holding History

Endurant Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-24,253	Closed	-$1.69M	–	67
2021 Q4	$1.69M	Buy	+24,253	New	+$1.76M	0.41%	46
2020 Q2	–	Sell	-33,453	Closed	-$1.12M	–	58
2020 Q1	$1.12M	Buy	+33,453	New	+$1.2M	0.51%	36
2019 Q4	–	Sell	-34,391	Closed	-$858K	–	56
2019 Q3	$858K	Sell	34,391 -184,647	-84%	-$5.27M	0.31%	40
2019 Q2	$6.54M	Sell	219,038 -47,539	-18%	-$1.39M	2.58%	16
2019 Q1	$7.14M	Buy	+266,577	New	+$8.1M	2.82%	14

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Endurant Capital Management's ATRC Position: Q1 2022 in Review

Endurant Capital Management sold out of AtriCure (ATRC) in Q1 2022, closing a stake of 24,253 shares — an estimated $1.69M sold.

Endurant Capital Management first reported a position in ATRC in Q1 2019 and held it in 5 quarters. The position peaked at $7.14M in Q1 2019. 217 funds tracked by Wall St. Rank hold ATRC as of Q1 2022.

Endurant Capital Management reported no remaining AtriCure position as of Q1 2022 after selling out during the quarter.
Endurant Capital Management sold 24,253 AtriCure shares in Q1 2022, an estimated $1.69M.
Endurant Capital Management first reported a position in AtriCure in Q1 2019 and held it in 5 quarters.
Endurant Capital Management's AtriCure position peaked at $7.14M in Q1 2019.
217 funds tracked by Wall St. Rank held AtriCure as of Q1 2022.

Based on Endurant Capital Management's 13F filing for Q1 2022, filed 16 May 2022.